Petros Pharmaceuticals, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Petros Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $3.71 million for the year ending 2024.

  • Petros Pharmaceuticals, Inc. showed a decrease of -72.2% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
  • This data is from Petros Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
  • XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2020 to 2024), Petros Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 78.4%.
  • Historical annual values: Fiscal year 2024: $3.71 million | Fiscal year 2023: $13.34 million | Fiscal year 2022: $9.43 million | Fiscal year 2021: $23.85 million | Fiscal year 2020: $17.14 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: